Fonte: JAMA Pediatrics. Unidade: FMRP
Assuntos: TUBERCULOSE (TRATAMENTO), QUIMIOTERAPIA COMBINADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VILLARINO, M. Elsa et al. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatrics, v. 169, n. 3, p. 247-255, 2015Tradução . . Disponível em: https://doi.org/10.1001/jamapediatrics.2014.3158. Acesso em: 03 nov. 2025.APA
Villarino, M. E., Scott, N. A., Weis, S. E., Weiner, M., Conde, M. B., Jones, B., et al. (2015). Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatrics, 169( 3), 247-255. doi:10.1001/jamapediatrics.2014.3158NLM
Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR, Mussi-Pinhata MM, Isaac M de L, Cervi MC. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid [Internet]. JAMA Pediatrics. 2015 ; 169( 3): 247-255.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1001/jamapediatrics.2014.3158Vancouver
Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR, Mussi-Pinhata MM, Isaac M de L, Cervi MC. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid [Internet]. JAMA Pediatrics. 2015 ; 169( 3): 247-255.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1001/jamapediatrics.2014.3158
